文献速递重症综合管理与镇静镇痛

针对重症患者不适的定制多组分项目可能减少普通ICU幸存者1年创伤后应激障碍

Tailored multicomponent program for discomfort reduction in critically ill patients may decrease post-traumatic stress disorder in general ICU survivors at 1 year.
PubMed 文献 · Intensive Care Med · 2019-01-30
一句话结论在30个ICU的普通成人幸存者中,实施针对不适的定制多组分项目与1年时创伤后应激障碍症状患病率降低相关(暴露组6.1% vs 未暴露组12.0%)。

本研究为前瞻性观察性比较效果队列研究,涉及30个ICU,是IPREA3集群随机对照试验的延伸。项目包括评估ICU相关自我感知不适、向医疗团队即时和每月反馈以及针对各站点的定制干预。共纳入1537例ICU幸存者,1年随访时475例未暴露患者和344例暴露患者有数据,暴露组57例(12.0%)vs未暴露组21例(6.1%)出现创伤后应激障碍(p=0.004)。考虑聚类并调整年龄、性别、McCabe分类和ICU相关自我感知总体不适评分后,暴露组1年时出现显著创伤后应激障碍症状的可能性显著低于未暴露组(p=0.015)。

要点

  • 在30个ICU的普通成人幸存者中,实施定制多组分不适 reduction 项目后,1年时创伤后应激障碍症状患病率暴露组为6.1%(21/344),未暴露组为12.0%(57/475)(p=0.004)。
  • 调整年龄、性别、McCabe分类和ICU相关自我感知总体不适评分并考虑聚类后,暴露组1年时出现显著创伤后应激障碍症状的可能性仍显著低于未暴露组(p=0.015)。
  • 该项目包括评估ICU相关自我感知不适、向医疗团队即时和每月反馈以及针对各站点的定制干预。
  • 研究为前瞻性观察性比较效果队列研究,是IPREA3集群随机对照试验的延伸,暴露定义为项目实施。

适用人群与场景

  • 普通成人ICU幸存者,来自30个ICU,暴露组为实施定制多组分项目的患者,未暴露组为未实施该项目的患者。

诊断标准与关键阈值

  • 1年时显著创伤后应激障碍症状基于事件影响量表修订版(IES-R)评估。

研究设计与关键结果

  • 研究类型为前瞻性观察性比较效果队列研究,涉及30个ICU,是IPREA3集群随机对照试验的延伸。
  • 共纳入1537例ICU幸存者,1年随访时475例未暴露患者和344例暴露患者有数据。
  • 1年时创伤后应激障碍患病率:未暴露组57例(12.0%)vs暴露组21例(6.1%)(p=0.004)。
  • 考虑聚类并调整年龄、性别、McCabe分类和ICU相关自我感知总体不适评分后,暴露组1年时出现显著创伤后应激障碍症状的可能性显著低于未暴露组(p=0.015)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性比较效果队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在ICU实施已证明可减少普通成人ICU幸存者自我感知不适的定制多组分项目,也降低了1年时显著创伤后应激障碍症状的患病率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Reducing discomfort in the intensive care unit (ICU) should have a positive effect on long-term outcomes. This study assessed whether a tailored multicomponent program for discomfort reduction was effective in reducing post-traumatic stress disorder (PTSD) symptoms at 1 year in general ICU survivors.

METHODS: This study is a prospective observational comparative effectiveness cohort study involving 30 ICUs. It was an extension of the IPREA3 study, a cluster-randomized controlled trial designed to assess the efficacy of a tailored multicomponent program to reduce discomfort in critically ill patients. The program included assessment of ICU-related self-perceived discomforts, immediate and monthly feedback to the healthcare team, and site-specific tailored interventions. The exposure was the implementation of this program. The eligible patients were exposed versus unexposed general adult ICU survivors. The prevalence of substantial PTSD symptoms at 1 year was assessed based on the Impact of Event Scale-Revised (IES-R).

RESULTS: Of the 1537 ICU survivors included in the study, 475 unexposed patients and 344 exposed patients had follow-up data at 1 year: 57 (12.0%) and 21 (6.1%) presented with PTSD at 1 year, respectively (p = 0.004). Considering the clustering and after adjusting for age, gender, McCabe classification, and ICU-related self-perceived overall discomfort score, exposed patients were significantly less likely than unexposed patients to have substantial PTSD symptoms at 1 year (p = 0.015).

CONCLUSIONS: Implementation of a tailored multicomponent program in the ICU that has proved to be effective for reducing self-perceived discomfort in general adult ICU survivors also reduced the prevalence of substantial PTSD symptoms at 1 year.

TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02762409.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kalfon P, Alessandrini M, Boucekine M, et al. Tailored multicomponent program for discomfort reduction in critically ill patients may decrease post-traumatic stress disorder in general ICU survivors at 1 year. Intensive Care Med. 2019. PMID: 30701294. doi:10.1007/s00134-018-05511-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。